
Pubmed-entry ::= {
  pmid 29655981,
  medent {
    em std {
      year 2018,
      month 4,
      day 16,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "Modular synthesis of new C-aryl-nucleosides and their anti-CML
 activity."
      },
      authors {
        names std {
          {
            name ml "Marzag H",
            affil str "Universite Cote d'Azur, CNRS, Institut de Chimie de
 Nice UMR 7272, 06108 Nice, France; Plant Chemistry, Organic and Bioorganic
 Synthesis Team, URAC23, Faculty of Sciences, B.P. 1014, GEOPAC Research
 Center, Mohammed V University, Rabat, Morocco."
          },
          {
            name ml "Zerhouni M",
            affil str "Universite Cote d'Azur, INSERM U1065, Centre
 Mediterraneen de Medecine Moleculaire (C3M), Batiment ARCHIMED, 151 Route de
 Saint-Antoine de Ginestiere, BP 2 3194, 06204 Nice Cedex 3, France."
          },
          {
            name ml "Tachallait H",
            affil str "Universite Cote d'Azur, CNRS, Institut de Chimie de
 Nice UMR 7272, 06108 Nice, France; Plant Chemistry, Organic and Bioorganic
 Synthesis Team, URAC23, Faculty of Sciences, B.P. 1014, GEOPAC Research
 Center, Mohammed V University, Rabat, Morocco."
          },
          {
            name ml "Demange L",
            affil str "Universite Cote d'Azur, CNRS, Institut de Chimie de
 Nice UMR 7272, 06108 Nice, France; Departement de Chimie, Universite Paris
 Descartes, Sorbonne Paris Cite, UFR des Sciences Pharmaceutiques, 4 avenue de
 l'Observatoire & UFR Biomedicale des Saints Peres, 45 rue des Saints Peres,
 Paris Fr-75006, France."
          },
          {
            name ml "Robert G",
            affil str "Universite Cote d'Azur, INSERM U1065, Centre
 Mediterraneen de Medecine Moleculaire (C3M), Batiment ARCHIMED, 151 Route de
 Saint-Antoine de Ginestiere, BP 2 3194, 06204 Nice Cedex 3, France."
          },
          {
            name ml "Bougrin K",
            affil str "Plant Chemistry, Organic and Bioorganic Synthesis Team,
 URAC23, Faculty of Sciences, B.P. 1014, GEOPAC Research Center, Mohammed V
 University, Rabat, Morocco."
          },
          {
            name ml "Auberger P",
            affil str "Universite Cote d'Azur, INSERM U1065, Centre
 Mediterraneen de Medecine Moleculaire (C3M), Batiment ARCHIMED, 151 Route de
 Saint-Antoine de Ginestiere, BP 2 3194, 06204 Nice Cedex 3, France."
          },
          {
            name ml "Benhida R",
            affil str "Universite Cote d'Azur, CNRS, Institut de Chimie de
 Nice UMR 7272, 06108 Nice, France; Mohamed VI Polytechnic University, UM6P,
 43150 Ben Guerir, Morocco. Electronic address: benhida@unice.fr."
          }
        }
      },
      from journal {
        title {
          iso-jta "Bioorg. Med. Chem. Lett.",
          ml-jta "Bioorg Med Chem Lett",
          issn "1464-3405",
          name "Bioorganic & medicinal chemistry letters"
        },
        imp {
          date std {
            year 2018,
            month 6,
            day 1
          },
          volume "28",
          issue "10",
          pages "1931-1936",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus received,
              date std {
                year 2018,
                month 2,
                day 13
              }
            },
            {
              pubstatus accepted,
              date std {
                year 2018,
                month 3,
                day 22
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2018,
                month 4,
                day 16,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2018,
                month 12,
                day 28,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2018,
                month 4,
                day 16,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 29655981,
        pii "S0960-894X(18)30258-0",
        doi "10.1016/j.bmcl.2018.03.063",
        other {
          db "ELocationID pii",
          tag str "S0960-894X(18)30258-0"
        },
        other {
          db "ELocationID doi",
          tag str "10.1016/j.bmcl.2018.03.063"
        }
      }
    },
    abstract "The C-aryl-ribosyles are of utmost interest for the development
 of antiviral and anticancer agents. Even if several synthetic pathways have
 been disclosed for the preparation of these nucleosides, a direct, few steps
 and modular approaches are still lacking. In line with our previous efforts,
 we report herein a one step - eco-friendly beta-ribosylation of aryles and
 heteroaryles through a direct Friedel-Craft ribosylation mediated by bismuth
 triflate, Bi(OTf)3. The resulting carbohydrates have been functionalized by
 cross-coupling reactions, leading to a series of new C-aryl-nucleosides (32
 compounds). Among them, we observed that 5d exerts promising
 anti-proliferative effects against two human Chronic Myeloid Leukemia (CML)
 cell lines, both sensitive (K562-S) or resistant (K562-R) to imatinib, the 
""gold standard of care"" used in this pathology. Moreover, we demonstrated
 that 5d kills CML cells by a non-conventional mechanism of cell death.",
    mesh {
      {
        term "Antineoplastic Agents",
        qual {
          {
            mp TRUE,
            subh "chemical synthesis"
          },
          {
            subh "pharmacology"
          }
        }
      },
      {
        term "Catalysis"
      },
      {
        term "Cell Proliferation",
        qual {
          {
            subh "drug effects"
          }
        }
      },
      {
        term "Drug Resistance, Neoplasm",
        qual {
          {
            subh "drug effects"
          }
        }
      },
      {
        term "Humans"
      },
      {
        term "Imatinib Mesylate",
        qual {
          {
            subh "pharmacology"
          }
        }
      },
      {
        term "K562 Cells"
      },
      {
        term "Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
        qual {
          {
            subh "metabolism"
          },
          {
            subh "pathology"
          }
        }
      },
      {
        term "Mesylates",
        qual {
          {
            subh "chemistry"
          }
        }
      },
      {
        term "Microtubule-Associated Proteins",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Nucleosides",
        qual {
          {
            subh "chemical synthesis"
          },
          {
            mp TRUE,
            subh "chemistry"
          },
          {
            subh "pharmacology"
          }
        }
      }
    },
    substance {
      {
        type nameonly,
        name "Antineoplastic Agents"
      },
      {
        type nameonly,
        name "Mesylates"
      },
      {
        type nameonly,
        name "Microtubule-Associated Proteins"
      },
      {
        type nameonly,
        name "Nucleosides"
      },
      {
        type cas,
        cit "51KD8E1741",
        name "Bi(OTf)3"
      },
      {
        type cas,
        cit "8A1O1M485B",
        name "Imatinib Mesylate"
      }
    },
    pmid 29655981,
    pub-type {
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    },
    status medline
  }
}


